Statin Drugs - The Truth. Part 3 In A 3-Part Series

 

You are receiving this because you or someone at your email address subscribed to HealthBeat News. If you are receiving this in error, or wish to no longer receive this newsletter, please click here to unsubscribe.  The Dangers Of Statins - The 3rd In A 3-Part Series 14 September 2009 This Week In HealthBeat News: The Dangers Of Statins - The 3rd In A 3-Part Series The Dangers Of Statins - The 3rd In A 3-Part Series HealthBeat News is pleased to bring you Part 3 of this special report on statin drugs and cholesterol that comes to us by special arrangement and kind permission of the authors, Sally Fallon and Mary Enig, PhD.  In Part 1 we looked at the "problem" of hypercholesterolemia (high cholesterol), how statins work, and just what cholesterol is and why our bodies need this controversial substance. In this part, Part 2 we looked at the statin drugs and learned of some of their many side-effects. In this final installment, Part 3, we will review a large number of scholarly studies on cholesterol and statins that the drug companies would rather you don't know about as they plainly demonstrate the dangers of these drugs and of our wrong-headed obsession with reducing cholesterol levels to un-natural and un-healthy levels. Finally, at the end of this part of the 3-part series, we'll introduce you to the authors and their achievements. You, our HealthBeat News readers, have received all three parts of this series before anyone else. We will now post it along with the full list of references on our Wellness Club website - but HealthBeat News subscribers have had access to this important and informative article first!   Dangers of Statin Drugs: What You Haven't Been Told About Popular Cholesterol-Lowering Medicines By Sally Fallon and Mary G. Enig, PhD Part 3 in a 3-Part series.   Any Benefits? Most doctors are convinced-and seek to convince their patients-that the benefits of statin drugs far outweigh the side effects. They can cite a number of studies in which statin use has lowered the number of coronary deaths compared to controls. But as Dr. Ravnskov has pointed out in his book The Cholesterol Myths,31 the results of the major studies up to the year 2000-the 4S, WOSCOPS, CARE, AFCAPS and LIPID studies-generally showed only small differences and these differences were often statistically insignificant and independent of the amount of cholesterol lowering achieved. In two studies, EXCEL, and FACAPT/TexCAPS, more deaths occurred in the treatment group compared to controls. Dr. Ravnskov's 1992 meta-analysis of 26 controlled cholesterol-lowering trials found an equal number of cardiovascular deaths in the treatment and control groups and a greater number of total deaths in the treatment groups.32 An analysis of all the big controlled trials reported before 2000 found that long-term use of statins for primary prevention of heart disase produced a 1 percent greater risk of death over 10 years compared to a placebo.33 Recently published studies do not provide any more justification for the current campaign to put as many people as possible on statin drugs.  [...Read more here]

 

761 S 1st St W, Box 900, Snowflake, AZ 85937, USA

To unsubscribe or change subscriber options visit: http://www.aweber.com/z/r/?zGwMrKystCysLJxsTOystEa0rMycbEwcbA==